Mckesson Corp
MCK
查看詳細走勢圖
813.800USD
-1.890-0.23%
收盤 12/12, 16:00（美東）報價延遲15分鐘
100.91B總市值
25.32本益比TTM
盤中分時
1分
30分
1小時
日k
週k
月k
日k
今天
-0.23%
5天
+0.64%
1月
-3.36%
6月
+11.76%
今年開始到現在
+42.79%
1年
+41.23%
查看詳細走勢圖
TradingKey Mckesson Corp股票評分
單位: USD 更新時間: 2025-12-12操作建議
Mckesson Corp當前公司基本面數據相對穩定，增長潛力很大。當前估值合理，在藥品行業排名6/159位。機構持股佔比非常高，近一個月多位分析師給出公司評級為買入。最高目標價934.03。中期看，股價處於上升通道。近一個月，市場表現一般，但公司基本面和技術面得分較高。目前股價在壓力位和支撐位之間，可以做區間波段操作。
Mckesson Corp評分
壓力支撐
由於公司未披露，未能獲取相關數據
多維評測
本期評分
上期評分
分析師目標
基於
18
分析師
買入
評級
934.031
目標均價
+17.06%
漲幅空間
數據免責聲明：分析師評級與目標價由LSEG提供，僅供參考，不應當作投資建議
Mckesson Corp亮點
亮點風險
McKesson Corporation is a diversified healthcare services company, which focuses on advancing health outcomes for patients everywhere. Its U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products in the United States (U.S.). The Prescription Technology Solutions (RxTS) segment helps solve medication access, affordability and adherence challenges for patients by working across healthcare to connect patients, pharmacies, pharmacy benefit managers, health plans, and biopharma companies. The Medical-Surgical Solutions provides medical-surgical supply distribution, logistics, and other services to healthcare providers, including physician offices, hospital reference labs, and home healthcare agencies. The International segment provides distribution and services to wholesale, institutional, and retail customers in Canada and Norway. It also offers oncology and specialty solutions.
行業龍頭
公司營業收入處於行業前列，最新年度總收入359.05B美元
業績高增長
公司營業收入穩步增長，連續3年增長29.76%
高分紅
公司屬於高分紅公司，最新股息支付率10.68%
估值合理
公司最新PE估值25.32，處於3年歷史合理位
機構減倉
最新機構持股112.70M股，環比減少1.97%
肯·費雪持倉
明星投資者肯·費雪持倉，最新持倉1.74K股
活躍度增加
近期活躍度增加，過去20天平均換手率0.19
Mckesson Corp新聞
即將為您帶來更多新聞，敬請期待。 。 。
財務指標
每股收益
由於公司未披露，未能獲取相關數據
營業總收入
由於公司未披露，未能獲取相關數據
Mckesson Corp簡介
McKesson Corporation is a diversified healthcare services company, which focuses on advancing health outcomes for patients everywhere. Its U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products in the United States (U.S.). The Prescription Technology Solutions (RxTS) segment helps solve medication access, affordability and adherence challenges for patients by working across healthcare to connect patients, pharmacies, pharmacy benefit managers, health plans, and biopharma companies. The Medical-Surgical Solutions provides medical-surgical supply distribution, logistics, and other services to healthcare providers, including physician offices, hospital reference labs, and home healthcare agencies. The International segment provides distribution and services to wholesale, institutional, and retail customers in Canada and Norway. It also offers oncology and specialty solutions.
公司代碼MCK
公司Mckesson Corp
CEOTyler (Brian Scott)
網址https://www.mckesson.com/
常見問題
Mckesson Corp(MCK)的當前股價是多少？
Mckesson Corp(MCK)的當前股價是 813.800。
Mckesson Corp 的股票代碼是什麼？
Mckesson Corp的股票代碼是MCK。
Mckesson Corp股票的52週最高點是多少？
Mckesson Corp股票的52週最高點是895.580。
Mckesson Corp股票的52週最低點是多少？
Mckesson Corp股票的52週最低點是558.130。
Mckesson Corp的市值是多少？
Mckesson Corp的市值是100.91B。
Mckesson Corp的淨利潤是多少？
Mckesson Corp的淨利潤為3.29B。
現在Mckesson Corp(MCK)的股票是買入、持有還是賣出？
根據分析師評級，Mckesson Corp(MCK)的總體評級為買入，目標價格為934.031。
Mckesson Corp(MCK)股票的每股收益（EPS TTM）是多少
Mckesson Corp(MCK)股票的每股收益（EPS TTM）是32.136。
相關品種
+1.83%
+0.76%
-0.31%
-0.51%
+0.15%
+1.33%
+0.11%
-0.23%
-2.28%
+0.23%
-0.37%
+1.37%
+2.40%
-0.16%
-0.73%
-0.74%
0.00%
-1.30%
-3.65%
